Biomerieux SA
OTC:BMXMF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biomerieux SA
OTC:BMXMF
|
FR |
|
S
|
Sunway Construction Group Bhd
KLSE:SUNCON
|
MY |
|
M
|
Merit SA
WSE:MEI
|
PL |
|
Kaluzhskaya Sbytovaya Kompaniya PAO
MOEX:KLSB
|
RU |
|
A
|
Abans Holdings Ltd
NSE:AHL
|
IN |
|
Upland Software Inc
NASDAQ:UPLD
|
US |
Wall Street
Price Targets
BMXMF Price Targets Summary
Biomerieux SA
According to Wall Street analysts, the average 1-year price target for
BMXMF
is 160.48 USD
with a low forecast of 133.84 USD and a high forecast of 192.01 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BMXMF's stock price target?
Price Target
160.48
USD
According to Wall Street analysts, the average 1-year price target for
BMXMF
is 160.48 USD
with a low forecast of 133.84 USD and a high forecast of 192.01 USD.
What is Biomerieux SA's Revenue forecast?
Projected CAGR
7%
For the last 14 years the
compound annual growth rate for
Biomerieux SA's revenue is
8%.
The projected
CAGR
for the next 3 years is
7%.
What is Biomerieux SA's Operating Income forecast?
Projected CAGR
22%
For the last 14 years the
compound annual growth rate for
Biomerieux SA's operating income is
5%.
The projected
CAGR
for the next 3 years is
22%.
What is Biomerieux SA's Net Income forecast?
Projected CAGR
22%
For the last 14 years the
compound annual growth rate for
Biomerieux SA's net income is
7%.
The projected
CAGR
for the next 3 years is
22%.
